mise avant
Share on:

Lesaffre acquires a majority interest in Envera,
an innovative US bioscience-based company

As part of its ongoing expansion strategy in nutrition and health, Lesaffre,
a global key player in the yeasts and fermentation industry today announces the acquisition of a majority interest in Envera.

Founded in 2004 by Michael L. Matheny, a long-time microbiologist entrepreneur
and executive, Envera is a full solution provider in the field of microbiology. Based
in West Chester, Pennsylvania, with experienced researchers, Envera develops
specific microbial-based products for a range of applications.

With this transaction, Lesaffre will enhance its presence and product offering in the
fast-growing nutritional ingredients and health sector. In July 2017, Lesaffre
announced an investment in Intralytix, another US biotechnology company and
leader in bacteriophage technology.

Antoine Baule, Lesaffre’s Chief Executive Officer says: “Lesaffre welcomes this
acquisition which is entirely in line with its strategic development objectives. We are
pleased to contribute to Envera’s development and to build upon the skills and
expertise of the team in place. The specific technology and the strains collection
developed by the company will provide a substantial addition to our current

Paolo Rossi, President of Lesaffre’s Nutrition and Health activity, adds: “Envera’s
impressive range of bacteria strains and products will enable us to widen our
offering of microorganisms to our customers, especially in the field of human,
animal and plant care activity. What’s unique about Envera is its experience in the
isolation, selection, production and formulation of microbial cultures.”

Michael L. Matheny, President of Envera comments: “I am delighted to have
partnered with Lesaffre, a French family owned company, known and recognized
internationally for its expertise and professionalism in fermentation. I am confident
the synergies between our companies, coupled with Lesaffre’s resources and
connections around the world, will enable Envera to significantly accelerate its

Share on:
Download the press release